Sulforaphane inhibits proliferation and invasive activity of everolimus-resistant kidney cancer cells in vitro

Although the mechanistic target of rapamycin (mTOR) inhibitor, everolimus, has improved the outcome of patients with renal cell carcinoma (RCC), improvement is temporary due to the development of drug resistance. Since many patients encountering resistance turn to alternative/complementary treatment...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Juengel, Eva, Maxeiner, Sebastian, Rutz, Jochen, Justin, Saira, Roos, Frederik, Khoder, Wael, Tsaur, Igor, Nelson, Karen, Bechstein, Wolf O., Haferkamp, Axel, Blaheta, Roman A.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356730/
https://ncbi.nlm.nih.gov/pubmed/27863441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13421
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller